Aesthetics Intradermal Injection Devices - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512243749

Publication Date:

December 6, 2024

Pages:

135

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Intradermal injections are the devices used for delivering the active ingredients to the dermis layer of skin. These devices are mainly used for exerting a local action or minimal systemic action, which is mainly due to the limited presence of blood vessels in the dermis layer. The advantages of intradermal injections such as less pain, reduction in adverse events and accurate dose delivery etc. are mainly responsible for its rising market penetration while innovation. This report focus on Intradermal Injection Devices in Aesthetics.

The global market for Aesthetics Intradermal Injection Devices was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Aesthetics Intradermal Injection Devices was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Aesthetics Intradermal Injection Devices was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Aesthetics Intradermal Injection Devices was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Aesthetics Intradermal Injection Devices include Becton Dickinson, Cardinal Health, West Pharmaceuticals Services, Terumo Corporation, NanoPass Technologies, Pharmajet, Idevax, Enusung and Crossject, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Aesthetics Intradermal Injection Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Aesthetics Intradermal Injection Devices by region & country, by Type, and by Application.
The Aesthetics Intradermal Injection Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aesthetics Intradermal Injection Devices.
麻豆原创 Segmentation
By Company
Becton Dickinson
Cardinal Health
West Pharmaceuticals Services
Terumo Corporation
NanoPass Technologies
Pharmajet
Idevax
Enusung
Crossject
Hindustan Syringes
Medical Devices
Novosanis
HIPRA
Lightnix Inc
Debiotech SA
Segment by Type:
Normal-sized Needles
Short Needles
Without Needles
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Aesthetics Intradermal Injection Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Aesthetics Intradermal Injection Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Aesthetics Intradermal Injection Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Aesthetics Intradermal Injection Devices Product Introduction
1.2 Global Aesthetics Intradermal Injection Devices 麻豆原创 Size Forecast
1.2.1 Global Aesthetics Intradermal Injection Devices Sales Value (2019-2030)
1.2.2 Global Aesthetics Intradermal Injection Devices Sales Volume (2019-2030)
1.2.3 Global Aesthetics Intradermal Injection Devices Sales Price (2019-2030)
1.3 Aesthetics Intradermal Injection Devices 麻豆原创 Trends & Drivers
1.3.1 Aesthetics Intradermal Injection Devices Industry Trends
1.3.2 Aesthetics Intradermal Injection Devices 麻豆原创 Drivers & Opportunity
1.3.3 Aesthetics Intradermal Injection Devices 麻豆原创 Challenges
1.3.4 Aesthetics Intradermal Injection Devices 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Aesthetics Intradermal Injection Devices Players Revenue Ranking (2023)
2.2 Global Aesthetics Intradermal Injection Devices Revenue by Company (2019-2024)
2.3 Global Aesthetics Intradermal Injection Devices Players Sales Volume Ranking (2023)
2.4 Global Aesthetics Intradermal Injection Devices Sales Volume by Company Players (2019-2024)
2.5 Global Aesthetics Intradermal Injection Devices Average Price by Company (2019-2024)
2.6 Key Manufacturers Aesthetics Intradermal Injection Devices Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Aesthetics Intradermal Injection Devices Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Aesthetics Intradermal Injection Devices
2.9 Aesthetics Intradermal Injection Devices 麻豆原创 Competitive Analysis
2.9.1 Aesthetics Intradermal Injection Devices 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Aesthetics Intradermal Injection Devices Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aesthetics Intradermal Injection Devices as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Normal-sized Needles
3.1.2 Short Needles
3.1.3 Without Needles
3.2 Global Aesthetics Intradermal Injection Devices Sales Value by Type
3.2.1 Global Aesthetics Intradermal Injection Devices Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Aesthetics Intradermal Injection Devices Sales Value, by Type (2019-2030)
3.2.3 Global Aesthetics Intradermal Injection Devices Sales Value, by Type (%) (2019-2030)
3.3 Global Aesthetics Intradermal Injection Devices Sales Volume by Type
3.3.1 Global Aesthetics Intradermal Injection Devices Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Aesthetics Intradermal Injection Devices Sales Volume, by Type (2019-2030)
3.3.3 Global Aesthetics Intradermal Injection Devices Sales Volume, by Type (%) (2019-2030)
3.4 Global Aesthetics Intradermal Injection Devices Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Aesthetics Intradermal Injection Devices Sales Value by Application
4.2.1 Global Aesthetics Intradermal Injection Devices Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Aesthetics Intradermal Injection Devices Sales Value, by Application (2019-2030)
4.2.3 Global Aesthetics Intradermal Injection Devices Sales Value, by Application (%) (2019-2030)
4.3 Global Aesthetics Intradermal Injection Devices Sales Volume by Application
4.3.1 Global Aesthetics Intradermal Injection Devices Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Aesthetics Intradermal Injection Devices Sales Volume, by Application (2019-2030)
4.3.3 Global Aesthetics Intradermal Injection Devices Sales Volume, by Application (%) (2019-2030)
4.4 Global Aesthetics Intradermal Injection Devices Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Aesthetics Intradermal Injection Devices Sales Value by Region
5.1.1 Global Aesthetics Intradermal Injection Devices Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Aesthetics Intradermal Injection Devices Sales Value by Region (2019-2024)
5.1.3 Global Aesthetics Intradermal Injection Devices Sales Value by Region (2025-2030)
5.1.4 Global Aesthetics Intradermal Injection Devices Sales Value by Region (%), (2019-2030)
5.2 Global Aesthetics Intradermal Injection Devices Sales Volume by Region
5.2.1 Global Aesthetics Intradermal Injection Devices Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Aesthetics Intradermal Injection Devices Sales Volume by Region (2019-2024)
5.2.3 Global Aesthetics Intradermal Injection Devices Sales Volume by Region (2025-2030)
5.2.4 Global Aesthetics Intradermal Injection Devices Sales Volume by Region (%), (2019-2030)
5.3 Global Aesthetics Intradermal Injection Devices Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Aesthetics Intradermal Injection Devices Sales Value, 2019-2030
5.4.2 North America Aesthetics Intradermal Injection Devices Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Aesthetics Intradermal Injection Devices Sales Value, 2019-2030
5.5.2 Europe Aesthetics Intradermal Injection Devices Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Aesthetics Intradermal Injection Devices Sales Value, 2019-2030
5.6.2 Asia Pacific Aesthetics Intradermal Injection Devices Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Aesthetics Intradermal Injection Devices Sales Value, 2019-2030
5.7.2 South America Aesthetics Intradermal Injection Devices Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Aesthetics Intradermal Injection Devices Sales Value, 2019-2030
5.8.2 Middle East & Africa Aesthetics Intradermal Injection Devices Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Aesthetics Intradermal Injection Devices Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Aesthetics Intradermal Injection Devices Sales Value
6.2.1 Key Countries/Regions Aesthetics Intradermal Injection Devices Sales Value, 2019-2030
6.2.2 Key Countries/Regions Aesthetics Intradermal Injection Devices Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Aesthetics Intradermal Injection Devices Sales Value, 2019-2030
6.3.2 United States Aesthetics Intradermal Injection Devices Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Aesthetics Intradermal Injection Devices Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Aesthetics Intradermal Injection Devices Sales Value, 2019-2030
6.4.2 Europe Aesthetics Intradermal Injection Devices Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Aesthetics Intradermal Injection Devices Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Aesthetics Intradermal Injection Devices Sales Value, 2019-2030
6.5.2 China Aesthetics Intradermal Injection Devices Sales Value by Type (%), 2023 VS 2030
6.5.3 China Aesthetics Intradermal Injection Devices Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Aesthetics Intradermal Injection Devices Sales Value, 2019-2030
6.6.2 Japan Aesthetics Intradermal Injection Devices Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Aesthetics Intradermal Injection Devices Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Aesthetics Intradermal Injection Devices Sales Value, 2019-2030
6.7.2 South Korea Aesthetics Intradermal Injection Devices Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Aesthetics Intradermal Injection Devices Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Aesthetics Intradermal Injection Devices Sales Value, 2019-2030
6.8.2 Southeast Asia Aesthetics Intradermal Injection Devices Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Aesthetics Intradermal Injection Devices Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Aesthetics Intradermal Injection Devices Sales Value, 2019-2030
6.9.2 India Aesthetics Intradermal Injection Devices Sales Value by Type (%), 2023 VS 2030
6.9.3 India Aesthetics Intradermal Injection Devices Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Becton Dickinson
7.1.1 Becton Dickinson Company Information
7.1.2 Becton Dickinson Introduction and Business Overview
7.1.3 Becton Dickinson Aesthetics Intradermal Injection Devices Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Becton Dickinson Aesthetics Intradermal Injection Devices Product Offerings
7.1.5 Becton Dickinson Recent Development
7.2 Cardinal Health
7.2.1 Cardinal Health Company Information
7.2.2 Cardinal Health Introduction and Business Overview
7.2.3 Cardinal Health Aesthetics Intradermal Injection Devices Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Cardinal Health Aesthetics Intradermal Injection Devices Product Offerings
7.2.5 Cardinal Health Recent Development
7.3 West Pharmaceuticals Services
7.3.1 West Pharmaceuticals Services Company Information
7.3.2 West Pharmaceuticals Services Introduction and Business Overview
7.3.3 West Pharmaceuticals Services Aesthetics Intradermal Injection Devices Sales, Revenue and Gross Margin (2019-2024)
7.3.4 West Pharmaceuticals Services Aesthetics Intradermal Injection Devices Product Offerings
7.3.5 West Pharmaceuticals Services Recent Development
7.4 Terumo Corporation
7.4.1 Terumo Corporation Company Information
7.4.2 Terumo Corporation Introduction and Business Overview
7.4.3 Terumo Corporation Aesthetics Intradermal Injection Devices Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Terumo Corporation Aesthetics Intradermal Injection Devices Product Offerings
7.4.5 Terumo Corporation Recent Development
7.5 NanoPass Technologies
7.5.1 NanoPass Technologies Company Information
7.5.2 NanoPass Technologies Introduction and Business Overview
7.5.3 NanoPass Technologies Aesthetics Intradermal Injection Devices Sales, Revenue and Gross Margin (2019-2024)
7.5.4 NanoPass Technologies Aesthetics Intradermal Injection Devices Product Offerings
7.5.5 NanoPass Technologies Recent Development
7.6 Pharmajet
7.6.1 Pharmajet Company Information
7.6.2 Pharmajet Introduction and Business Overview
7.6.3 Pharmajet Aesthetics Intradermal Injection Devices Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Pharmajet Aesthetics Intradermal Injection Devices Product Offerings
7.6.5 Pharmajet Recent Development
7.7 Idevax
7.7.1 Idevax Company Information
7.7.2 Idevax Introduction and Business Overview
7.7.3 Idevax Aesthetics Intradermal Injection Devices Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Idevax Aesthetics Intradermal Injection Devices Product Offerings
7.7.5 Idevax Recent Development
7.8 Enusung
7.8.1 Enusung Company Information
7.8.2 Enusung Introduction and Business Overview
7.8.3 Enusung Aesthetics Intradermal Injection Devices Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Enusung Aesthetics Intradermal Injection Devices Product Offerings
7.8.5 Enusung Recent Development
7.9 Crossject
7.9.1 Crossject Company Information
7.9.2 Crossject Introduction and Business Overview
7.9.3 Crossject Aesthetics Intradermal Injection Devices Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Crossject Aesthetics Intradermal Injection Devices Product Offerings
7.9.5 Crossject Recent Development
7.10 Hindustan Syringes
7.10.1 Hindustan Syringes Company Information
7.10.2 Hindustan Syringes Introduction and Business Overview
7.10.3 Hindustan Syringes Aesthetics Intradermal Injection Devices Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Hindustan Syringes Aesthetics Intradermal Injection Devices Product Offerings
7.10.5 Hindustan Syringes Recent Development
7.11 Medical Devices
7.11.1 Medical Devices Company Information
7.11.2 Medical Devices Introduction and Business Overview
7.11.3 Medical Devices Aesthetics Intradermal Injection Devices Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Medical Devices Aesthetics Intradermal Injection Devices Product Offerings
7.11.5 Medical Devices Recent Development
7.12 Novosanis
7.12.1 Novosanis Company Information
7.12.2 Novosanis Introduction and Business Overview
7.12.3 Novosanis Aesthetics Intradermal Injection Devices Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Novosanis Aesthetics Intradermal Injection Devices Product Offerings
7.12.5 Novosanis Recent Development
7.13 HIPRA
7.13.1 HIPRA Company Information
7.13.2 HIPRA Introduction and Business Overview
7.13.3 HIPRA Aesthetics Intradermal Injection Devices Sales, Revenue and Gross Margin (2019-2024)
7.13.4 HIPRA Aesthetics Intradermal Injection Devices Product Offerings
7.13.5 HIPRA Recent Development
7.14 Lightnix Inc
7.14.1 Lightnix Inc Company Information
7.14.2 Lightnix Inc Introduction and Business Overview
7.14.3 Lightnix Inc Aesthetics Intradermal Injection Devices Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Lightnix Inc Aesthetics Intradermal Injection Devices Product Offerings
7.14.5 Lightnix Inc Recent Development
7.15 Debiotech SA
7.15.1 Debiotech SA Company Information
7.15.2 Debiotech SA Introduction and Business Overview
7.15.3 Debiotech SA Aesthetics Intradermal Injection Devices Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Debiotech SA Aesthetics Intradermal Injection Devices Product Offerings
7.15.5 Debiotech SA Recent Development
8 Industry Chain Analysis
8.1 Aesthetics Intradermal Injection Devices Industrial Chain
8.2 Aesthetics Intradermal Injection Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Aesthetics Intradermal Injection Devices Sales Model
8.5.2 Sales Channel
8.5.3 Aesthetics Intradermal Injection Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Becton Dickinson
Cardinal Health
West Pharmaceuticals Services
Terumo Corporation
NanoPass Technologies
Pharmajet
Idevax
Enusung
Crossject
Hindustan Syringes
Medical Devices
Novosanis
HIPRA
Lightnix Inc
Debiotech SA

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.